ILSI-Biomed Israel

Italy-Israel Bilateral conference during Biomed 2011

The Embassy of Italy in Tel Aviv In collaboration with Israel Italy Chamber of Commerce and Industry Cordially invite you to attend the FIFTH Italian Israeli Conference on Life Sciences: “Collaboration and Innovation in Cancer Research and Treatment” Tuesday, May 24, 2011 Dan Panorama Hotel, Tel Aviv From 09.00 to 13.00 for informations info@italia-israel.com Tweet

Israeli Breath test could identify head and neck cancer

An 'electronic nose' can distinguish between molecules found in the breath of head-and-neck cancer patients and those of healthy people, according to the results of a small, initial study published in the British Journal of Cancer. Researchers from Technion – Israel Institute of Technology collected breath samples from 82 people from three groups: head-and-neck cancer patients, lung cancer patients and healthy people. The team examined the differences in the molecules present in the exhal...

Prof. Michael Karin and Prof. Alexander Polyakov – Winners of 2010 Harvey Prize

Prof. Michael Karin and Prof. Alexander Polyakov are the winners of the Technion’s 2010 Harvey Prize. Prof. Karin, from the University of California, San Diego, will receive the prize in the field of human health. He discovered the strong link between obesity, inflammation and cancer. The judges decided to award the prize to Prof. Karin for “his pioneering contribution that led to deciphering the molecular mechanism through which mammalian cells react to cytokines which cause inflammation...

A film which explains about a new therapeutic vaccine for cancer – amazing!

Here is the film which explains about ImMucin, a new therapeutic vaccine for cancer which is currently in clinical trials in Myeloma patients. You are also invited to visit Vaxil BioTherapeutics site. Tweet

Molecular imaging to diagnose, monitor and treat disease

Molecular probes from Israel's Aposense show areas of disease on a cellular level and can even provide a picture that reveals the efficacy of chemotherapy. Israeli biotech company Aposense offers a futuristic way of diagnosing, monitoring and treating disease through molecules designed to detect cell death (apoptosis). While apoptosis is a universal process in cell biology, it plays a role in most medical disorders. Targeting cells undergoing apoptosis, for imaging or delivering therapy, can ...

Research at Rambam: One Session of Waterpipe Smoking May Significantly Affect Health

Rambam researchers have shown that even one waterpipe session significantly affected users’ lung function, and increased blood pressure and pulse. It boosted amounts of the toxin carboxyhemoglobin to levels that may require medical attention, oxygen administration or hyperbaric treatment. To achieve this toxic level, one must smoke between 10-100 cigarettes. Additionally, levels of exhaled NO, a molecule that helps protect the heart, lung and blood vessels greatly decreased. Research subjec...

Cancer Biomarkers in the Blood- a research from Technion

Finding the hallmarks of cancer in blood is hard to do — cancer-related proteins are present only in small amounts, are difficult to sort from all of the other circulating proteins, and tend to be eliminated quickly by the body. But one group has devised a method that could turn that around. At the Technion-Israel Institute of Technology in Haifa, Arie Admon and his team have devised a method that combines immunoaffinity purification, microcapillary chromatography, and mass spectrometry to separ...

BioView Ltd. Ranked in Top 50 Fastest Growing Israeli Technology Companies in Deloitte Survey

BioView Ltd. (TASE:BIOV) announced that it ranked as one of the 50 fastest growing technology companies in Israel. The Deloitte Technology Fast 50, one of the Israel's foremost technology award programs, is a ranking of the country's 50 fastest-growing technology companies based on percentage growth over five years. The Fast 50 program honors business growth, technological innovation and Israel entrepreneurial spirit. BioView’s automated scanning microscope and image analysis systems...

BioCancell Announces Success in Pre-Clinical Trial of New Therapy BC-821 on Glioblastoma

BioCancell Therapeutics, Inc. has successfully completed pre-clinical animal studies, using mice, that examined the use of BioCancell's new product candidate BC-821 as a treatment for glioblastoma (the most common and agressive type of primary human brain tumor). The research, carried out by Dr. Doron Amit in the Hebrew University laboratory of Prof. Abraham Hochberg, BioCancell's founder and chief scientist, showed that BC-821 succeeded in significantly inhibiting brain tumor volume growth in a...

New Research From Israel: Aposesne

In a special Jewish Week feature, three Israeli cutting edge research projects are being introduced. One of them is Aposesne, an Israeli pharmaceutical company that is targeting a process that is integral to nearly every illness — apoptosis, or cellular death. Photo credit: ardelfin from morguefile.com “Apoptosis is associated with almost every medical disorder,” said Yoram Ashery, CEO of Aposense, a clinical stage molecular imaging and drug development company that completed its Initial P...